Publications by authors named "Magali Heintzelmann"

Background: Milrinone has emerged as an option to treat delayed cerebral ischemia after subarachnoid hemorrhage. However, substantial variation exists in the administration of this drug. We retrospectively assessed the effectiveness of 2 protocols in patients with angiographically proven cerebral vasospasm.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Magali Heintzelmann"

  • - Magali Heintzelmann's research focuses on the treatment of cerebral vasospasm associated with subarachnoid hemorrhage, particularly analyzing the use of Milrinone as a therapeutic option.
  • - In her 2019 study, she evaluated the effectiveness of two different protocols for administering Milrinone, highlighting substantial variations in treatment practices among patients.
  • - The findings aim to provide a clearer understanding of the optimal administration of Milrinone to improve outcomes in individuals experiencing delayed cerebral ischemia following subarachnoid hemorrhage.